Clinical Trial Update: Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight [Phase 2]

View source ↗

Summary

A Phase 2 exploratory trial evaluates whether combining dapagliflozin and exenatide can affect body weight in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BYETTA (Exenatide)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: Uppsala University | Conditions: Obesity | Phase 2 | Status: COMPLETED